https://assets.publishing.service.gov.uk/media/650ade0f52e73c001254dc08/covid-19-autumn-2023-impact-assessment.pdf<\/a><\/p> <\/p>
On the advice of the JCVI, NHS eligibility is focussed on those at higher risk of serious outcomes. However, all vaccines that have been licensed by the Medicines and Healthcare products Regulatory Agency for use in the United Kingdom may be prescribed by physicians privately as well as through the NHS. Currently COVID-19 vaccines are not available privately but as is the case for many other vaccines, manufacturers and providers are able to set up a private market alongside the NHS offer when they consider this viable and appropriate. The Government is supportive of the emergence of a private market for COVID-19 vaccines and is engaging with relevant parties on this.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"}
}
, "answeringMemberConstituency" : {"_value" : "Lewes"}
, "answeringMemberPrinted" : {"_value" : "Maria Caulfield"}
, "dateOfAnswer" : {"_value" : "2023-12-27", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2023-12-27T12:21:54.543Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2023-12-05", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of allowing people that are not currently eligible for covid-19 booster vaccines to (a) purchase them at an affordable price and (b) receive them free of charge if they are eligible for free prescriptions on levels of people returning to work.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1528", "label" : {"_value" : "Biography information for Sir Mike Penning"}
}
, "tablingMemberConstituency" : {"_value" : "Hemel Hempstead"}
, "tablingMemberPrinted" : [{"_value" : "Sir Mike Penning"}
], "uin" : "5266"}
, {"_about" : "http://data.parliament.uk/resources/1670738", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1670738/answer", "answerText" : {"_value" : "
The independent Joint Committee on Vaccination and Immunisation (JCVI) advises Government health departments on immunisations and the prevention of infectious disease. On 8 August 2023, the Government accepted advice from the JCVI on who should be offered vaccination in autumn 2023. This includes residents and staff in a care home for older adults, all adults aged 65 years old and over, persons aged six months to 64 years old in a clinical risk group, frontline health and social care workers, persons aged 12 to 64 years old who are household contacts and persons aged 16 to 64 years old who are carers.<\/p>
The clinical risk groups for COVID-19 vaccination are defined in the UK Health Security Agency\u2019s \u2018Green Book\u2019 on vaccines and immunisation Chapter 14a tables 3 and 4. However, as stated in the Green Book, the examples of eligible conditions in these tables are not exhaustive. Within these broad groups, the prescriber may need to apply clinical judgment to consider the risk of COVID-19 exacerbating any underlying condition that a patient may have, as well as the risk of serious illness from COVID-19 itself. The fact that an individual condition is not explicitly cited in the Green Book should therefore not prevent vaccination being offered where clinically appropriate.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"}
}
, "answeringMemberConstituency" : {"_value" : "Lewes"}
, "answeringMemberPrinted" : {"_value" : "Maria Caulfield"}
, "dateOfAnswer" : {"_value" : "2023-11-24", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2023-11-24T11:19:55.74Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2023-11-17", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential merits of allowing GPs to prescribe a covid-19 booster vaccination to vulnerable patients not specifically listed as being in a clinical risk group.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1528", "label" : {"_value" : "Biography information for Sir Mike Penning"}
}
, "tablingMemberConstituency" : {"_value" : "Hemel Hempstead"}
, "tablingMemberPrinted" : [{"_value" : "Sir Mike Penning"}
], "uin" : "2395"}
, {"_about" : "http://data.parliament.uk/resources/1664460", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1664460/answer", "answerText" : {"_value" : "
The United Kingdom has extensive legislative controls to ensure the safety and security of biological research into human, animal and plant pathogens. All life sciences companies operating in the UK must adhere to UK ethics standards, research codes of conduct and associated legal obligations.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"}
}
, "answeringMemberConstituency" : {"_value" : "Lewes"}
, "answeringMemberPrinted" : {"_value" : "Maria Caulfield"}
, "dateOfAnswer" : {"_value" : "2023-10-23", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2023-10-23T16:08:32.953Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2023-10-13", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Research: Viral Diseases"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, whether his Department has taken recent steps to help tackle the growth of (a) gain-of-function research and (b) any other research that modifies a virus or other pathogen to make it more transmissible, virulent and pathogenic in (i) the UK and (ii) other countries; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1528", "label" : {"_value" : "Biography information for Sir Mike Penning"}
}
, "tablingMemberConstituency" : {"_value" : "Hemel Hempstead"}
, "tablingMemberPrinted" : [{"_value" : "Sir Mike Penning"}
], "uin" : "202313"}
, {"_about" : "http://data.parliament.uk/resources/1624710", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1624710/answer", "answerText" : {"_value" : "
The Parliamentary Under Secretary of State (Lord Markham) replied to the Rt hon. Member on 4 May 2023.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"}
}
, "answeringMemberConstituency" : {"_value" : "Colchester"}
, "answeringMemberPrinted" : {"_value" : "Will Quince"}
, "dateOfAnswer" : {"_value" : "2023-05-10", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2023-05-10T15:24:20.55Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2023-04-28", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Members: Correspondence"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, when he plans to respond to the correspondence from the hon. Member for Hemel Hempstead of 9 November 2022 and 12 January 2023, reference MP77327.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1528", "label" : {"_value" : "Biography information for Sir Mike Penning"}
}
, "tablingMemberConstituency" : {"_value" : "Hemel Hempstead"}
, "tablingMemberPrinted" : [{"_value" : "Sir Mike Penning"}
], "uin" : "183238"}
, {"_about" : "http://data.parliament.uk/resources/1601557", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1601557/answer", "answerText" : {"_value" : "
National Health Service trusts and NHS foundation trusts own their own land and buildings and are responsible for the sale or disposal of identified assets. Trusts work with integrated care boards, including the local authority and NHS England, on planning and optimising their estate.<\/p>
The Watford Campus Agreement was signed in 2013 by West Hertfordshire Teaching Hospitals NHS Trust, Watford Borough Council and the Local asset backed vehicle LABV, which comprises Watford Borough Council and the property company Kier. It was approved by the Trust Board. Regulatory authority is required at the point when expenditure exceeds the delegated £15 million limit. To date, the Trust has contributed £7 million towards the construction of the access road, which opened in 2016. The Watford Campus Agreement has an end date of 2033 unless previously terminated by agreement of all parties.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"}
}
, "answeringMemberConstituency" : {"_value" : "Colchester"}
, "answeringMemberPrinted" : {"_value" : "Will Quince"}
, "dateOfAnswer" : {"_value" : "2023-03-14", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2023-03-14T10:28:49.793Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2023-03-06", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Health Services: Watford"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to the agreements with Watford Borough Council and the property company Kier signed by the West Hertfordshire Teaching Hospitals NHS Trust in relation to the Watford Health Campus Partnership LLP, which runs until 2033 unless previously terminated by agreement, by what authority that Trust signed those agreements; what the legal basis is of that authority; and whether that authority has or had a start or end date.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1528", "label" : {"_value" : "Biography information for Sir Mike Penning"}
}
, "tablingMemberConstituency" : {"_value" : "Hemel Hempstead"}
, "tablingMemberPrinted" : [{"_value" : "Sir Mike Penning"}
], "uin" : "158833"}
, {"_about" : "http://data.parliament.uk/resources/1588079", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1588079/answer", "answerText" : {"_value" : "
National Health Service trusts and NHS foundation trusts own their own land and buildings and are responsible for the sale or disposal of identified assets. Trusts work with integrated care boards, including the local authority and NHS England, on planning and optimising their estate.<\/p>
The NHS has advised that the arrangement between West Hertfordshire Teaching Hospitals NHS Trust and Watford Borough Council and Kier was signed in 2013 and has a termination date of 2033 unless otherwise agreed by the parties. The housing regeneration is ongoing, and the hospital redevelopment is now part of the New Hospital Programme.<\/p>
The Trust will make contributions to infrastructure costs as the work progresses and details of these will be made public in the normal way. To date, a £7 million contribution has been made by the Trust to the development of Thomas Sawyer Way, an access road which has an ambulance-only section, as well as access for staff, patients, and visitors to the new multi-storey car park. There have been no subsequent legal agreements which have changed either the original obligations or the rights applying to the West Hertfordshire Teaching Hospitals NHS Trust.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"}
}
, "answeringMemberConstituency" : {"_value" : "Colchester"}
, "answeringMemberPrinted" : {"_value" : "Will Quince"}
, "dateOfAnswer" : {"_value" : "2023-03-01", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "148560"}
, {"_value" : "148561"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2023-03-01T11:51:22.597Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2023-02-22", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Health Services: Watford"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, whether any subsequent legal agreements have been reached to change the original (a) obligations and (b) rights applying to the West Hertfordshire Teaching Hospitals NHS Trust as set out in the June 2013 agreement for the Watford Health Campus Partnership LLP.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1528", "label" : {"_value" : "Biography information for Sir Mike Penning"}
}
, "tablingMemberConstituency" : {"_value" : "Hemel Hempstead"}
, "tablingMemberPrinted" : [{"_value" : "Sir Mike Penning"}
], "uin" : "150419"}
], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&AnsweringBody.=Department+of+Health+and+Social+Care&tablingMemberConstituency=Hemel+Hempstead", "page" : 0, "startIndex" : 1, "totalResults" : 146, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}